Bioceres : Form6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rules 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

Dated October 10, 2019

Commission File Number: 001-38405

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant's name into English)

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-Fx

Form 40-Fo

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

EXPLANATORY NOTE

The following exhibit is filed as part of this Form 6-K:

Exhibit List

Exhibit No.

Description

99.1Notice and Proxy Materials for the 2019 Annual General Meeting of Bioceres Crop Solutions Corp. 2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		BIOCERES CROP SOLUTIONS CORP.
		(Registrant)
Dated: October 10, 2019	By:	By:	/s/ Federico Trucco
		Name:	Federico Trucco
		Title:	Chief Executive Officer
		3

Exhibit 99.1

www.biocerescrops.com

Ocampo 210 bis Predio CCT Rosario

(2000) Rosario, Santa Fe, Argentina

T: (54) 341 4861100

E: [e-mail]

October 10, 2019

Dear Shareholder,

You are cordially invited to attend the 2019 Annual General Meeting (the "Annual General Meeting") of Bioceres Crop Solutions Corp. (the "Company" or "Bioceres Crop Solutions") to be held at 12:00 p.m. EDT on October 31, 2019 at the Company's legal counsel's office, 1345 Avenue of the Americas, New York, NY 10105. Information concerning the matters to be considered and voted upon at the Annual General Meeting is set out in the attached Convening Notice and Proxy Statement.

The Board of Directors has fixed October 3, 2019 (5:00 p.m. Argentina time, 4:00 p.m. EDT) as the record date for the Annual General Meeting (the "Record Date"), and only holders of record of shares at such time will be entitled to notice of or to vote at the Annual General Meeting or any adjournment thereof.

If you are unable to attend the Annual General Meeting in person or you wish to be represented, please authorize a proxy to vote your shares in accordance with the instructions you received. This will not prevent you from voting your shares in person if you subsequently choose to attend our Annual General Meeting.

Please note that powers of attorney or proxy cards must be received by the tabulation agent (Continental Stock), no later than 11:59 p.m. EDT, on October 30, 2019 in order for such votes to be taken into account.

On behalf of the Board of Directors, we thank you for your continued support.

Sincerely,

/s/ Federico Trucco Federico Trucco Chief Executive Officer

www.biocerescrops.com

Ocampo 210

bis Predio CCT Rosario

(2000) Rosario, Santa Fe, Argentina

T: (54) 341 4861100

E: [e-mail]

Convening Notice to

the Annual General Meeting

to be held on October 31, 2019 at 12:00 p.m. EDT at 1345 Avenue of the Americas

New York, NY 10105

October 10, 2019

Dear Shareholder,

The Board of Directors of Bioceres Crop Solutions Corp. (the "Company") is pleased to invite you to attend the 2019 Annual General Meeting (the "Annual General Meeting"), to be held on October 31, 2019 at 12:00 p.m. EDT at 1345 Avenue of the Americas, New York, NY 10105 with the following agenda:

Agenda of the 2019 Annual General Meeting

1. Consider the report of the Board of Directors of the Company and the report of the independent auditor on the Company's consolidated financial statements for the financial year ended June 30, 2019 and approve the Company's consolidated financial statements for the financial year ended June 30, 2019.
2. Consider and vote upon the establishment of equity compensation plans pursuant to which cash options or shares may be granted to officers, directors and employees of the Company.
3. Consider and vote upon the ratification of the appointment of Gloria Montaron Estrada as a Director of the Company.
4. Consider and vote upon the ratification of appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company.

The holders of a majority of the ordinary shares being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorized representative or proxy shall be a quorum for all purposes, including adopting the resolutions at the Annual General Meeting.